Hematopoietic stem cell (HSC) transplantation can restore a new functional hematopoietic system in recipients in cases where the recipient’s own system is not functional, or for example, leukemic. However, the number of available donor HSCs is sometimes too low for successful transplantation. Expansion of HSCs and thus, HSC self-renewal ex vivo would greatly improve transplantation therapy in the clinic. In vivo, HSCs expand significantly in the niche, but establishing protocols that result in HSC expansion ex vivo remains challenging. In this review, we discuss current knowledge of niche biology, the intrinsic regulators of HSC self-renewal in vivo, and introduce novel niche-informed strategies of HSC expansion ex vivo.